STRATEGIC OBJECTIVES

• Development of detection systems based on aptamer technology that aim to improve the diagnosis and/or prognosis of different pathologies. Thus, enabling better patient care and cost savings for the health system.
• Development of aptamers against targets involved in different pathologies (cancer, infections, etc.) for use in the design of drugs that will translate to new therapeutic options for patients.
• Identification of new therapeutic targets in cancer.

RESEARCH LINES

• Development of aptamers with a therapeutic potential.
• Development of aptamer-based diagnostic systems.
• Involvement of kinase Mnk1b in tumourigenesis